Strong CYP3A Inducers Concomitant use of Tivozanib with a strong CYP3A inducer decreases tivozanib exposure, which may reduce Tivozanib anti-tumor activity. Avoid concomitant use of strong CYP3A inducers with Tivozanib.
from FDA,2021.03
Drug Interactions and Contraindications of TivozanibWhen combined with certain d···【more】
Release date:2026-05-28Recommended:64